Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
about
A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccinesVirus like particle-based vaccines against emerging infectious disease viruses.A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.Progress in developing virus-like particle influenza vaccines.Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models.Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored VaccinesLack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunityDetermination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodiesAnalytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
P2860
Q30201991-6E41D6C7-5FF3-455B-8606-427BB73E426BQ30249025-16A87BCE-4E17-4E00-9B74-DEFB0453DACCQ30365391-684F5F1A-568B-447C-A9EE-0A0E7D580E93Q30386640-97D15F11-ACAA-4E8C-8774-9AB733D5F652Q30397144-2819F599-9571-4C6F-89ED-3A45BBCDBDE5Q30423166-FBFAE063-DA61-4DD7-A7A6-7ABA14B7FD54Q35550576-894C60BB-7777-4667-8C23-C7CE762A6D6AQ35928588-3B32F02E-1480-4129-8716-22C6CFDE2160Q36086236-8A0020F0-12BC-4D5E-934C-7A1617FDB42EQ36350940-40F3DA89-F961-498E-8294-87EE8BB4C3F2Q36849574-B72FCC47-079F-4B4E-8FDD-84711DDC4776Q47575744-4474E3D4-AC10-4506-BD26-4355B1DD7460Q52620757-2F6A2C8F-2BB1-452A-A3F0-F4E7FB556501
P2860
Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Production and characterizatio ...... magglutinin and neuraminidase.
@ast
Production and characterizatio ...... magglutinin and neuraminidase.
@en
type
label
Production and characterizatio ...... magglutinin and neuraminidase.
@ast
Production and characterizatio ...... magglutinin and neuraminidase.
@en
prefLabel
Production and characterizatio ...... magglutinin and neuraminidase.
@ast
Production and characterizatio ...... magglutinin and neuraminidase.
@en
P2093
P1433
P1476
Production and characterizatio ...... magglutinin and neuraminidase.
@en
P2093
Benjamin Blumberg
Falko Schmeisser
Jackeline Soto
Jacqueline Muller
Jerry P Weir
Joan E Adamo
Rachel Friedman
P304
P356
10.1016/J.VACCINE.2012.03.033
P407
P577
2012-03-29T00:00:00Z